Skip to content
10-Q

Quarterly Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-12-000003

← back to feed
Filed
Feb 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Dec 31, 2011 111.55M sh
Operating Cash Flow Q2 2012 · Dec 31, 2011 −$1.79M
Operating Cash Flow Q2 2012 · Dec 31, 2010 −$40.21K
Operating Cash Flow Q2 2012 · Dec 31, 2010 −$72.03K
Cash And Equivalents Q2 2012 · Dec 31, 2011 $10.03K
Cash And Equivalents Q2 2012 · Jun 30, 2011 $8.68K
Stockholders Equity Q2 2012 · Dec 31, 2011 −$1.98M
Stockholders Equity Q2 2012 · Jun 30, 2011 −$1.97M
Total Liabilities Q2 2012 · Dec 31, 2011 $2.01M
Total Liabilities Q2 2012 · Jun 30, 2011 $1.98M
Current Assets Q2 2012 · Dec 31, 2011 $21.83K
Current Assets Q2 2012 · Jun 30, 2011 $16.89K
Net Income Q2 2012 · Dec 31, 2011 −$1.75M
Net Income Q2 2012 · Dec 31, 2010 −$35.07K
Net Income Q2 2012 · Dec 31, 2010 −$56.9K
Operating Income Q2 2012 · Dec 31, 2011 −$2.04M
Operating Income Q2 2012 · Dec 31, 2010 −$35.07K
Operating Income Q2 2012 · Dec 31, 2010 −$56.9K